NASDAQ: FEMY - Femasys Inc.

Rentabilité sur six mois: +1.8%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions Femasys Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Femasys Inc.

Femasys Inc., a biomedical company, develops novel solutions for women's healthcare market in the United States and internationally.

plus de détails
The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. In addition, the company provides non-surgical product technologies. It offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 2021-06-18
ISIN US31447E1055
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.femasys.com
Цена ао 1.5
Changement de prix par jour: -1.74% (1.15)
Changement de prix par semaine: +3.67% (1.09)
Changement de prix par mois: +8.65% (1.04)
Changement de prix sur 3 mois: +0.8929% (1.12)
Changement de prix sur six mois: +1.8% (1.11)
Changement de prix par an: +15.9% (0.975)
Evolution du prix sur 3 ans: -72.57% (4.12)
Evolution du prix sur 5 ans: 0% (1.13)
Evolution des prix sur 10 ans: 0% (1.13)
Evolution des prix depuis le début de l'année: +2.73% (1.1)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 13.28 1
P/BV 0.7754 9
P/E 0 0
EV/EBITDA 0.0577 10
Total: 5

Efficacité

Nom Signification Grade
ROA, % -51.33 0
ROE, % -77.63 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.343 10
Total: 9.6

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 15.39 3
Rentabilité Ebitda, % 29.11 4
Rentabilité EPS, % -25.6 0
Total: 2.2
Plus de détails

Établissements Volume Partager, %
Clear Street LLC 249900 1.15
Clear Creek Financial Management, LLC 236769 1.09
Bank of America Corporation 165043 0.76
CM Management, LLC 125000 0.58
Barclays PLC 99003 0.46
Vanguard Group Inc 87623 0.4
Tri Locum Partners, LP 76605 0.35
Geode Capital Management, LLC 75902 0.35
Sassicaia Capital Advisers, LLC 71931 0.33
Renaissance Technologies, LLC 69126 0.32



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Dov Elefant Chief Financial Officer 595.14k 1967 (58 années)
Mr. Daniel Scott Currie COO, Senior VP & Secretary 548.15k 1964 (61 année)
Ms. Mary An Merchant J.D., Ph.D. Vice President of Counsel & Intellectual Property N/A
Dr. Jeffrey Marcus M.D., M.S. Chief Medical Advisor N/A
Ms. Christine Thomas Senior VP of Regulatory & Clinical Affairs N/A 1973 (52 année)
Dr. James H. Liu M.D. Chief Medical Officer N/A
Mr. Richard Spector Chief Commercial Officer N/A 1971 (54 année)
Ms. Kathy Lee-Sepsick M.B.A. Founder, President, CEO & Director 804.67k 1968 (57 années)
Ms. Sue Owens Vice President of Sales
Ms. Naomi Phaneuf Vice President of Marketing

Adresse: United States, Suwanee. GA, 3950 Johns Creek Court - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.femasys.com